WO2007054969A3 - Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride - Google Patents

Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride Download PDF

Info

Publication number
WO2007054969A3
WO2007054969A3 PCT/IN2006/000376 IN2006000376W WO2007054969A3 WO 2007054969 A3 WO2007054969 A3 WO 2007054969A3 IN 2006000376 W IN2006000376 W IN 2006000376W WO 2007054969 A3 WO2007054969 A3 WO 2007054969A3
Authority
WO
WIPO (PCT)
Prior art keywords
lercanidipine
preparation
amorphous form
hydrochloride
lercanidipine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000376
Other languages
French (fr)
Other versions
WO2007054969A2 (en
Inventor
V V Shrinivas Rao A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrent Pharmaceuticals Ltd
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Priority to EP06842760A priority Critical patent/EP1963254A2/en
Publication of WO2007054969A2 publication Critical patent/WO2007054969A2/en
Publication of WO2007054969A3 publication Critical patent/WO2007054969A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to new, improved and industrially viable process for the preparation of Lercanidipine or its pharmaceutically acceptable salts using novel derivatives of 2,N-dimethyl-N-(3,3-diphenylpropyl)-l -amino compounds and novel polymorphs of Lercanidipine hydrochloride, its process of preparation.
PCT/IN2006/000376 2005-09-21 2006-09-19 Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride Ceased WO2007054969A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06842760A EP1963254A2 (en) 2005-09-21 2006-09-19 Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1164/MUM/2005 2005-09-21
IN1164MU2005 2005-09-21
IN1593/MUM/2005 2005-12-19
IN1593MU2005 2005-12-19

Publications (2)

Publication Number Publication Date
WO2007054969A2 WO2007054969A2 (en) 2007-05-18
WO2007054969A3 true WO2007054969A3 (en) 2007-11-01

Family

ID=38023682

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000376 Ceased WO2007054969A2 (en) 2005-09-21 2006-09-19 Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride

Country Status (2)

Country Link
EP (1) EP1963254A2 (en)
WO (1) WO2007054969A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR052918A1 (en) 2005-02-25 2007-04-11 Recordati Ireland Ltd LERCANIDIPINE AMORFO CHLORHYDRATE
AU2007280272A1 (en) 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
KR100928995B1 (en) * 2007-10-31 2009-11-26 (주)에이에스텍 Amorphous anhydrous lercanidipine and its improved preparation
EP2513116B1 (en) 2009-12-16 2015-08-19 Hetero Research Foundation Polymorphs of darunavir
US8853430B2 (en) 2010-05-20 2014-10-07 Hetero Research Foundation Crystalline hydrochloride salt of darunavir
EP2444394A1 (en) * 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153016A2 (en) * 1984-02-14 1985-08-28 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153016A2 (en) * 1984-02-14 1985-08-28 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEONARDI A ET AL: "Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 33, no. 5, June 1998 (1998-06-01), pages 399 - 420, XP004127371, ISSN: 0223-5234 *

Also Published As

Publication number Publication date
EP1963254A2 (en) 2008-09-03
WO2007054969A2 (en) 2007-05-18

Similar Documents

Publication Publication Date Title
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
WO2009139817A3 (en) Crystalline pharmaceutical and methods of preparation and use thereof
WO2007058583A3 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
WO2010001257A3 (en) Novel solid state forms of laquinimod and its sodium salt
WO2007103456A3 (en) Piperazine and piperidine biaryl derivatives
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2009141718A3 (en) Process for the preparation of prostaglandin analogues and intermediates thereof
TW200714586A (en) Crystalline forms of a biphenyl compound
WO2006067103A3 (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
WO2008093838A1 (en) Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof
WO2004043920A8 (en) Polymorphs of bicifadine hydrochloride
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
EP3020704A3 (en) Crystalline polymorphs of clevidipine butyrate
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2009125975A3 (en) Combination of mitiglinide and metformin and process for preparing same
WO2006081515A3 (en) Duloxetine hydrochloride polymorphs
WO2007054969A3 (en) Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
EA200701687A1 (en) Amorphous hydrochloride lorkanidipine
WO2008074693A3 (en) Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
WO2008059513A3 (en) Compounds suitable as modulators of hdl
WO2007119120A3 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
WO2008107797A3 (en) Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006842760

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006842760

Country of ref document: EP